Marker Therapeutics 1 article

Marker Therapeutics is a cell-therapy biotechnology company whose scientific profile centers on multi-antigen T-cell therapy. Its work connects multiTAA-specific T cells with MT-601 tumor-associated antigen T cells, placing the company in a specific mechanistic and therapeutic niche rather than a broad life-science category. That combination of hematologic malignancy cellular therapy with lymphoma T-cell immunotherapy helps distinguish the biotechnology profile of Marker Therapeutics.